Vaxcyte Ownership | Who Owns Vaxcyte?

Overview ForecastFinancials Chart Transcripts

Vaxcyte Ownership Summary

Vaxcyte is owned by 108.42% institutional investors, 0.67% insiders. Fmr is the largest institutional shareholder, holding 10.58% of PCVX shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.97% of its assets in Vaxcyte shares.

PCVX Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Vaxcyte	108.42%	0.67%	-9.09%
Sector	Healthcare Stocks	486.50%	11.08%	-397.59%
Industry	Biotech Stocks	304.14%	11.08%	-215.23%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Fmr	13.09M	10.58%	$1.07B
Vanguard group	11.96M	9.67%	$979.18M
Ra capital management	11.97M	8.80%	$389.01M
Janus henderson group	10.58M	8.55%	$865.61M
Blackrock	9.94M	8.48%	$750.56M
Blackrock funding, inc. /de	10.64M	7.82%	$345.98M
T. rowe price investment management	6.00M	4.41%	$195.10M
Wellington management group llp	4.44M	3.59%	$363.79M
Capital research global investors	4.77M	3.51%	$155.13M
Price t rowe associates inc /md/	3.97M	3.21%	$324.74M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Pivotal bioventure partners investment advisor	1.31M	26.30%	$42.43M
Kynam capital management, lp	3.07M	10.75%	$99.86M
Saturn v capital management	544.22K	7.17%	$17.69M
Ra capital management	11.97M	6.55%	$389.01M
Eversept partners, lp	1.30M	3.88%	$42.21M
Ghost tree capital	150.00K	3.55%	$11.33M
Paradigm biocapital advisors lp	1.70M	2.93%	$64.06M
Deep track capital, lp	2.15M	2.24%	$69.90M
Novo	916.16K	2.10%	$29.78M
Ikarian capital	305.00K	1.90%	$9.92M

Top Buyers

Holder	Shares	% Assets	Change
T. rowe price investment management	6.00M	0.12%	3.30M
Goldman sachs group	3.13M	0.04%	2.18M
Deep track capital, lp	2.15M	2.24%	1.40M
Norges bank	1.10M	0.01%	1.10M
Westfield capital management co lp	3.07M	0.42%	913.76K

Top Sellers

Holder	Shares	% Assets	Change
Fmr	13.09M	0.06%	-2.71M
Darwin global management	-	-	-2.20M
Commodore capital lp	-	-	-1.65M
Capital research global investors	4.77M	0.03%	-1.34M
Avoro capital advisors	-	-	-1.00M

New Positions

Holder	Shares	% Assets	Change	Value
Norges bank	1.10M	0.01%	1.10M	$90.07M
Voloridge investment management	633.20K	0.08%	633.20K	$20.59M
Balyasny asset management	104.84K	0.01%	104.84K	$3.41M
Nan fung trinity (hk)	104.25K	0.41%	104.25K	$3.39M
Bnp paribas arbitrage, snc	91.27K	0.00%	91.27K	$7.47M

Sold Out

Holder	Change
Dinuzzo private wealth	-1.00
Jfs wealth advisors	-1.00
Global financial private client	-1.00
Mai capital management	-2.00
Capital performance advisors llp	-3.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Jun 30, 2025	302	-7.93%	147,482,023	1.73%	108	0.95%	183	-2.66%	77	-20.62%
Mar 31, 2025	35	-89.64%	28,246,930	-79.94%	20	0.16%	20	-90.10%	6	-93.02%
Dec 31, 2024	130	-62.54%	38,665,990	-71.44%	31	0.26%	83	-61.03%	32	-63.64%
Sep 30, 2024	344	25.09%	135,391,305	10.49%	109	1.00%	210	32.08%	88	18.92%
Jun 30, 2024	275	5.36%	122,540,457	3.83%	104	0.94%	159	7.43%	74	-6.33%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Total Stock Mkt Idx Inv	3.86M	2.97%	-80.72K
Vanguard US Total Market Shares ETF	3.67M	2.85%	587.74K
Vanguard Small Cap Index	2.98M	2.29%	-19.86K
iShares Russell 2000 ETF	2.96M	2.28%	-56.28K
Vanguard Health Care Inv	2.83M	2.20%	-1.03M
Janus Inst Mid Cap Growth CF	2.64M	2.05%	1.26M
Janus Henderson Enterprise D	2.64M	2.04%	-
Janus Concentrated Growth CF	2.16M	1.67%	-
Janus Henderson Forty S	2.16M	1.66%	-
SPDR® S&P Biotech ETF	2.00M	1.55%	49.34K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Mar 05, 2025	Eydelman Mikhail	SVP, GEN COUNSEL & CORP SEC	Sell	$8.11K
Mar 05, 2025	Eydelman Mikhail	SVP, GEN COUNSEL & CORP SEC	Sell	$184.49K
Mar 05, 2025	Eydelman Mikhail	SVP, GEN COUNSEL & CORP SEC	Sell	$161.11K
Mar 03, 2025	Wassil Jim	CHIEF OPERATING OFFICER	Sell	$153.95K
Mar 03, 2025	Wassil Jim	CHIEF OPERATING OFFICER	Sell	$432.21K

Insider Transactions Trends

Date	Buy	Sell
2025 Q2	-	-
2025 Q1	-	32
2024 Q4	-	68
2024 Q3	-	54
2024 Q2	-	46

PCVX Ownership FAQ

Who Owns Vaxcyte?

Vaxcyte shareholders are primarily institutional investors at 108.42%, followed by 0.67% insiders and -9.09% retail investors. The average institutional ownership in Vaxcyte's industry, Biotech Stocks , is 304.14%, which Vaxcyte falls below.

Who owns the most shares of Vaxcyte?

Vaxcyte’s largest shareholders are Fmr (13.09M shares, 10.58%), Vanguard group (11.96M shares, 9.67%), and Ra capital management (11.97M shares, 8.80%). Together, they hold 29.05% of Vaxcyte’s total shares outstanding.

Does Blackrock own Vaxcyte?

Yes, BlackRock owns 8.48% of Vaxcyte, totaling 9.94M shares as of Jun 2024. This represents 0.02% of BlackRock's total assets, with a market value of 750.56M$. In the last quarter, BlackRock increased its holdings by 426.84K shares, a 4.49% change.

Who is Vaxcyte’s biggest shareholder by percentage of total assets invested?

Pivotal bioventure partners investment advisor is Vaxcyte’s biggest shareholder by percentage of total assets invested, with 26.30% of its assets in 1.31M Vaxcyte shares, valued at 42.43M$.

Who is the top mutual fund holder of Vaxcyte shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Vaxcyte shares, with 2.97% of its total shares outstanding invested in 3.86M Vaxcyte shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools